+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Programmed death-1/programmed death-ligand 1 pathway and T cell exhaustion in sepsis

Programmed death-1/programmed death-ligand 1 pathway and T cell exhaustion in sepsis

Zhonghua Nei Ke Za Zhi 58(2): 158-160


Please choose payment method:

(PDF emailed within 1 workday: $29.90)

Accession: 066446326

Download citation: RISBibTeXText

PMID: 30704206

Related references

Targeting the programmed cell death 1: programmed cell death ligand 1 pathway reverses T cell exhaustion in patients with sepsis. Critical Care 18(1): R3, 2015

Programmed Cell Death-1/Programmed Death-ligand 1 Pathway: A New Target for Sepsis. Chinese Medical Journal 130(8): 986-992, 2017

Prognostic value of programmed death-1, programmed death-ligand 1, programmed death-ligand 2 expression, and CD8(+) T cell density in primary tumors and metastatic lymph nodes from patients with stage T1-4N+M0 gastric adenocarcinoma. Chinese Journal of Cancer 36(1): 61, 2018

Programmed Cell Death-1/Programmed Death-Ligand 1 Blockade Improves Survival of Animals with Sepsis: A Systematic Review and Meta-Analysis. Biomed Research International 2018: 1969474, 2018

Involvement of the programmed death-1/programmed death-1 ligand pathway in CD4+CD25+ regulatory T-cell activity to suppress alloimmune responses. Transplantation 83(6): 774-782, 2007

The programmed death 1/programmed death ligand 1 inhibitory pathway is up-regulated in rheumatoid synovium and regulates peripheral T cell responses in human and murine arthritis. Arthritis and Rheumatism 62(7): 1870-1880, 2010

Programmed cell death protein-1/programmed cell death ligand-1 pathway inhibition and predictive biomarkers: understanding transforming growth factor-beta role. Translational Lung Cancer Research 4(6): 728-742, 2016

Soluble programmed cell death protein-1 and programmed cell death ligand-1 in sepsis. Critical Care 22(1): 146, 2018

Development of Inhibitors of the Programmed Cell Death-1/Programmed Cell Death-Ligand 1 Signaling Pathway. Journal of Medicinal Chemistry 2018, 2018

Clinical significance and therapeutic potential of the programmed death-1 ligand/programmed death-1 pathway in human pancreatic cancer. Clinical Cancer Research 13(7): 2151-2157, 2007

Genetic, immunologic, and immunohistochemical analysis of the programmed death 1/programmed death ligand 1 pathway in human systemic lupus erythematosus. Arthritis and Rheumatism 60(1): 207-218, 2009

Role played by the programmed death-1-programmed death ligand pathway during innate immunity against Mycobacterium tuberculosis. Journal of Infectious Diseases 202(4): 524-532, 2010

Outcomes of long-term responders to anti-programmed death 1 and anti-programmed death ligand 1 when being rechallenged with the same anti-programmed death 1 and anti-programmed death ligand 1 at progression. European Journal of Cancer 101: 160-164, 2018

Blockade of programmed death-1/programmed death ligand pathway enhances the antitumor immunity of human invariant natural killer T cells. Cancer Immunology, ImmunoTherapy 65(12): 1477-1489, 2016

Use of the 22C3 anti-programmed death-ligand 1 antibody to determine programmed death-ligand 1 expression in cytology samples obtained from non-small cell lung cancer patients. Cancer Cytopathology 126(4): 264-274, 2018